Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 28:2022:5169892.
doi: 10.1155/2022/5169892. eCollection 2022.

Effect of Kvass on Improving Functional Dyspepsia in Rats

Affiliations

Effect of Kvass on Improving Functional Dyspepsia in Rats

Zhanmei Shao et al. Comput Math Methods Med. .

Abstract

Functional dyspepsia (FD) is a common digestive system disease, and probiotics in the treatment of FD have a good curative effect. Patients with gastrointestinal diseases often show a poor response to traditional drug treatments and suffer from adverse reactions. Kvass can be used as a functional drink without side effects to improve the symptoms of FD patients. The results showed that compared with those of the model group, the body weight and food intake of the treatment group were significantly increased (P < 0.05), and the gastric residual rate of the treatment group was significantly decreased (P < 0.05); the amount of pepsin in the treatment group was significantly higher than that in the model group (P < 0.05); a high dose of Kvass could increase the contents of ghrelin, motilin (MTL), and gastrin (GAS) in the plasma and decrease the contents of vasoactive intestinal peptide (VIP) in the plasma; the contents of ghrelin, MTL, and GAS in the gastric antrum were also increased in the high-dose group. Kvass beverage can significantly improve the gastrointestinal function of rats, which may be because it can improve the contents of ghrelin, MTL, GAS, and VIP in both the serum and gastric antrum by regulating the expression of short-chain fatty acids in the colon.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Results of body weight and feed intake in rats ((a) feed intake; (b) body weight). Compared with the normal group, the difference was significant (P < 0.05). ∗∗Significantly different from that of the normal group (P < 0.01). #Compared with the model group, the difference was significant (P < 0.05).
Figure 2
Figure 2
Effect of Kvass on the contents of ghrelin, MTL, GAS, and VIP in rats ((a) effects of Kvass on the contents of ghrelin, MTL, GAS, and VIP in the rat plasma; (b) effects of Kvass on the contents of ghrelin, MTL, GAS, and VIP in the rat gastric antrum).
Figure 3
Figure 3
Detection of gastric residual rate and intestinal propulsion rate in rats.

References

    1. Osipova M. V. Use of clarifying agents in technological process of kvass production. IOP Conference Series: Earth and Environmental Science . 2020;613(1, article 012100) doi: 10.1088/1755-1315/613/1/012100. - DOI
    1. Lucas W., Matthias C., Karlien G., et al. 464 Efficacy and safety of spore-forming probiotics in functional dyspepsia: a randomized placebo-controlled trial. Gastroenterology . 2021;160(6) doi: 10.1016/s0016-5085(21)00969-0. - DOI
    1. Lorenzo D., Gabriele M., Dario P., Luigi P., Giuseppe M. Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies. Journal of International Medical Research . 2021;49(1) doi: 10.1177/0300060520982657. - DOI - PMC - PubMed
    1. Zhang J., Wu H. M., Wang X., et al. Efficacy of prebiotics and probiotics for functional dyspepsia. Medicine . 2020;99(7, article e19107) doi: 10.1097/MD.0000000000019107. - DOI - PMC - PubMed
    1. Agah S., Akbari A., Heshmati J., et al. Systematic review with meta-analysis: effects of probiotic supplementation on symptoms in functional dyspepsia. Journal of Functional Foods . 2020;68:p. 103902. doi: 10.1016/j.jff.2020.103902. - DOI